The Scientist - Home

The report provides evidence that goes against concerns that Monsanto’s popular herbicide, Roundup, is carcinogenic. 

A combination gene-and-cell therapy has given a boy with a grievous skin disease a new lease on life, and has resolved a dermatology debate to boot.

A US judge issues a broad injunction that allows the society to demand that technology companies actively associated with the site block access to it.

Asprosin—involved in a rare disease called neonatal progeroid syndrome—targets neurons to stimulate appetite, and blocking the hormone wards off weight gain in rodents.

If approved, patisiran will be the first RNAi therapeutic on the market. 

Andean highlander genomes possess cardiovascular-related variants, while populations from other regions evolved different solutions to manage the lack of oxygen.

In people with epilepsy, transcranial alternating current stimulation (tACS) does not affect memory-related brainwaves as widely claimed, researchers report.

Soluble adenylyl cyclase measures and responds to pH changes in coral cells, but whether it can help the animals withstand ocean acidification is not yet known.

Every human brain is far more unique, adaptable, and vulnerable than ever suspected.

A four-time winner of the USA Memory Championship is helping scientists understand how the brain works.

Researchers aim for a routine screen to detect the neurodegenerative disease—decades before symptoms appear.

These insect transplants have the potential to wreak economic havoc by outcompeting native insects and destroying crops.